Enhanced StefinA and Sprr2 expression during papilloma formation in HPV8 transgenic mice

Journal of Dermatological Science

Volumn 62, Issue 2, 2011, Pages 84-90

  Lazić, Daliborka ^a   Alborzi, Farnoosh ^a   Marcuzzi, Gian Paolo ^a   Angel, Peter ^b   Hess, Jochen ^b,c   Pfister, Herbert ^a   Akgül, Baki ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

HPV8; Skin papilloma development; Transgenic mice

Indexed keywords

MESSENGER RNA; PROLINE RICH PROTEIN; SMALL PROLINE RICH PROTEIN 2; STEFIN A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EPIDERMIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 8; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SKIN CARCINOGENESIS; SKIN PAPILLOMA; TISSUE REGENERATION; TRANSGENIC MOUSE; ULTRAVIOLET RADIATION; UPREGULATION; WART VIRUS; WILD TYPE;

ANIMALS; BETAPAPILLOMAVIRUS; CORNIFIED ENVELOPE PROLINE-RICH PROTEINS; CYSTATIN A; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; KERATIN-14; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMA; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; TISSUE DISTRIBUTION;

EID: 79954587383     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2011.02.006     Document Type: Article

References (31)

1. Nindl I., Gottschling M., Stockfleth E. Human papillomaviruses and non-melanoma skin cancer: basic virology and clinical manifestations. Dis Markers 2006, 23(4):247-259.
2. Madan V., Lear J.T., Szeimies R.M. Non-melanoma skin cancer. Lancet 2010, 375(9715):673-685.
3. Staples M.P., Elwood M., Burton R.C., Williams J.L., Marks R., Giles G.G. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006, 184:6-10.
4. Akgül B., Cooke J.C., Storey A. HPV-associated skin disease. J Pathol 2006, 208(2):165-175.
5. Bouwes Bavinck J.N., Feltkamp M., Struijk L., ter Schegget J. Human papillomavirus infection and skin cancer risk in organ transplant recipients. J Investig Dermatol Symp Proc 2001, 6(3):207-211.
6. Pfister H. Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003, 31:52-56.
7. Weissenborn S.J., Nindl I., Purdie K., Harwood C., Proby C., Breuer J., et al. Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol 2005, 125(1):93-97.
8. Struijk L., Hall L., van der Meijden E., Wanningen P., Bavinck J.N., Neale R., et al. Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2006, 15(3):529-535.
9. Plasmeijer E.I., Neale R.E., de Koning M.N., Quint W.G., McBride P., Feltkamp M.C., et al. Persistence of betapapillomavirus infections as a risk factor for actinic keratoses, precursor to cutaneous squamous cell carcinoma. Cancer Res 2009, 69(23):8926-8931.
10. Bouwes Bavinck J.N., Stark S., Petridis A.K., Marugg M.E., Ter Schegget J., Westendorp R.G., et al. The presence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated humanpapillomavirus type 8 in patients with actinic keratoses. Br J Dermatol 2000, 142(1):103-109.
11. Masini C., Fuchs P.G., Gabrielli F., Stark S., Sera F., Ploner M., et al. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol 2003, 139(7):890-894.
12. Schaper I.D., Marcuzzi G.P., Weissenborn S.J., Kasper H.U., Dries V., Smyth N., et al. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res 2005, 65(4):1394-1400.
13. Marcuzzi G.P., Hufbauer M., Kasper H.U., Weissenborn S.J., Smola S., Pfister H. Spontaneous tumor development in human papillomavirus type 8 E6 transgenic mice and rapid induction by UV-light exposure and wounding. J Gen Virol 2009, 90(Pt 12):2855-2864.
14. Pfefferle R., Marcuzzi G.P., Akgul B., Kasper H.U., Schulze F., Haase I., et al. The human papillomavirus type 8 E2 protein induces skin tumors in transgenic mice. J Invest Dermatol 2008, 128(9):2310-2315.
15. Hufbauer M., Lazić D., Akgül B., Brandsma J.L., Pfister H., Weissenborn S.J. Enhanced human papillomavirus type 8 oncogene expression levels are crucial for skin tumorigenesis in transgenic mice. Virology 2010, 403(2):128-136.
16. Durchdewald M., Guinea-Viniegra J., Haag D., Riehl A., Lichter P., Hahn M., et al. Podoplanin is a novel fos target gene in skin carcinogenesis. Cancer Res 2008, 68(17):6877-6883.
17. Akgül B., Karle P., Adam M., Fuchs P.G., Pfister H.J. Dual role of tumor suppressor p53 in regulation of DNA replication and oncogene E6-promoter activity of epidermodysplasia verruciformis-associated human papillomavirus type 8. Virology 2003, 308(2):279-290.
18. Proby C.M., Purdie K.J., Sexton C.J., Purkis P., Navsaria H.A., Stables J.N., et al. Spontaneous keratinocyte cell lines representing early and advanced stages of malignant transformation of the epidermis. Exp Dermatol 2000, 9(2):104-117.
19. Akgül B., Ghali L., Davies D., Pfister H., Leigh I.M., Storey A. HPV8 early genes modulate differentiation and cell cycle of primary human adult keratinocytes. Exp Dermatol 2007, 16(7):590-599.
20. Duffy C.L., Phillips S.L., Klingelhutz A.J. Microarray analysis identifies differentiation-associated genes regulated by human papillomavirus type 16 E6. Virology 2003, 314(1):196-205.
21. Vasilopoulos Y., Walters K., Cork M.J., Duff G.W., Sagoo G.S., Tazi-Ahnini R. Association analysis of the skin barrier gene cystatin A at the PSORS5 locus in psoriatic patients: evidence for interaction between PSORS1 and PSORS5. Eur J Hum Genet 2008, 16(8):1002-1009.
22. Takahashi H., Komatsu N., Ibe M., Ishida-Yamamoto A., Hashimoto Y., Iizuka H., et al. suppresses ultraviolet B-induced apoptosis of keratinocytes. J Dermatol Sci 2007, 46(3):179-187.
23. De Heller-Milev M., Huber M., Panizzon R., Hohl D. Expression of small proline rich proteins in neoplastic and inflammatory skin diseases. Br J Dermatol 2000, 143(4):733-740.
24. Kainu K., Kivinen K., Zucchelli M., Suomela S., Kere J., Inerot A., et al. Association of psoriasis to PGLYRP and SPRR genes at PSORS4 locus on 1q shows heterogeneity between Finnish, Swedish and Irish families. Exp Dermatol 2009, 18(2):109-115.
25. Iizuka H., Takahashi H., Honma M., Ishida-Yamamoto A. Unique keratinization process in psoriasis: late differentiation markers are abolished because of the premature cell death. J Dermatol 2004, 31(4):271-276.
26. Lehr E., Hohl D., Huber M., Brown D. Infection with human papillomavirus alters expression of the small proline rich proteins 2 and 3. J Med Virol 2004, 72(3):478-483.
27. Patel S., Kartasova T., Segre J.A. Mouse Sprr locus: a tandem array of coordinately regulated genes. Mamm Genome 2003, 14(2):140-148.
28. Roberson, Bowcock Psoriasis genetics: breaking the barrier. Trends Genet 2010, 26(9):415-423.
29. Pasić A., Lipozencić J., Ceović R., Kostović K. The genetics of psoriasis-selected novelties in 2008. Acta Dermatovenerol 2009, 17(3):176-181.
30. O'Shaughnessy R.F., Akgũl B., Storey A., Pfister H., Harwood C.A., Byrne C. Cutaneous human papillomaviruses down-regulate AKT1, whereas AKT2 up-regulation and activation associates with tumors. Cancer Res 2007, 67(17):8207-8215.
31. Proksch E., Holleran W.M., Menon G.K., Elias P.M., Feingold K.R. Barrier function regulates epidermal lipid and DNA synthesis. Br J Dermatol 1993, 128(5):473-482.